The groundbreaking success of Viagra undeniably revolutionized the medication landscape, but betting in companies heavily reliant on generic versions presents a complex picture. Although early returns were impressive, the end of patents and the emergence of discounted alternatives have weakened sales. Thus, a thorough evaluation of current financia